所有图片(1)
About This Item
线性分子式:
ZrOCl2 · 8H2O
CAS号:
分子量:
322.25
EC 号:
MDL编号:
UNSPSC代码:
12352112
PubChem化学物质编号:
方案:
≥99.5%
表单:
liquid
推荐产品
等级
puriss. p.a.
方案
≥99.5%
表单
liquid
杂质
≤0.001% heavy metals (as Pb)
痕量阴离子
sulfate (SO42-): ≤50 mg/kg
痕量阳离子
Fe: ≤10 mg/kg
Ti: ≤50 mg/kg
适用性
passes test for suitability as micro reagent
SMILES字符串
O.O.O.O.O.O.O.O.Cl[Zr](Cl)=O
InChI
1S/2ClH.8H2O.O.Zr/h2*1H;8*1H2;;/q;;;;;;;;;;;+2/p-2
InChI key
IZYKRMGFEBSOSO-UHFFFAOYSA-L
正在寻找类似产品? 访问 产品对比指南
一般描述
Crystal structure studies of zirconium(IV) oxychloride octahydrate (zirconyl chloride octahydrate, zirconium(IV) oxide chloride) confirms the presence of [Zr4(OH)8(H2O)16]8+ tetranuclear complex in its crystals. Crystal structure has been evaluated by least-squares method with new three-dimensional data.
应用
Zirconium(IV) oxychloride octahydrate (Zirconyl chloride octahydrate, Zirconium(IV) oxide chloride, ZrOCl2.8H2O) may be used for the preparation of 2-substituted benzothiazoles. ZrOCl2.8H2O dissolved in ethanol may be employed as a standard green solvent during the synthesis of quinoxaline derivatives.
警示用语：
Danger
危险声明
危险分类
Skin Corr. 1B
储存分类代码
8B - Non-combustible corrosive hazardous materials
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
Zirconium (IV) oxide chloride and anhydrous copper (II) sulfate mediated synthesis of 2-substituted benzothiazoles.
Moghaddam FM, et al.
Heteroatom Chem., 17(2), 136-141 (2006)
A new catalytic method for eco-friendly synthesis of quinoxalines by zirconium (IV) oxide chloride octahydrate under mild conditions.
Jafarpour M, et al.
Letters in Organic Chemistry, 8(3), 202-209 (2011)
Refinement of the crystal structure of zirconyl chloride octahydrate.
Mak TCW.
Canadian Journal of Chemistry, 46(22), 3491-3497 (1968)
D Skrtic et al.
Dental materials : official publication of the Academy of Dental Materials, 12(5), 295-301 (1996-09-01)
The rationale for this study was based on the hypothesis that the mechanical strength of methacrylate composites containing the bioactive filler, amorphous calcium phosphate, can be enhanced by synthesizing this filler in the presence of glass-forming agents. Specifically, this study
R Scholtens et al.
The International journal of artificial organs, 5(1), 33-36 (1982-01-01)
Patients suffering from primary hyperoxaluria show elevated plasma concentrations of oxalic acid and glyoxylic acid. The in vitro adsorption of these compounds into activated charcoal, a series of neutral and ion exchange resins and onto hydrous zirconium oxide has been
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门